Trevena CEO to Present at the Canaccord Genuity 34th Annual Growth Conference Aug 7, 2014 4:19 pm EDT
Trevena Initiates Phase 1 Multiple Ascending Dose Study of TRV734 for Acute and Chronic Pain Aug 6, 2014 7:00 am EDT
Trevena to Host Conference Call to Discuss Second Quarter 2014 Results on August 12 Aug 5, 2014 7:00 am EDT
Results of Phase 1b Clinical Trial Comparing Trevena’s TRV130 to Morphine Published in the Journal Pain Jun 24, 2014 7:00 am EDT